Category: Hematology
Cancer Care in 2024 – Novel Therapies Delivering Greater Personalized Care!
In the ever-evolving landscape of cancer care in 2024, a host of innovative treatment modalities are revolutionizing our approach to this complex disease. Antibody Drug…
Gene Therapy in Sickle Cell Disease – A Revolutionary Approach
Gene therapy is a revolutionary medical approach that aims to treat or prevent diseases by modifying the genes inside our cells. Genes are like instruction…
Strength and Serenity: Navigating Cancer Treatment with Resilience
A cancer diagnosis can be one of life’s most challenging moments, impacting not only the body but also testing one’s mental and emotional resilience. The…
Acalabrutinib-Containing Regimens Show Superior Progression-Free Survival in Elevate-TN Trial for Chronic Lymphocytic Leukemia
The results of the Elevate-TN trial, a phase 3 clinical trial evaluating the efficacy of acalabrutinib-containing regimens in patients with chronic lymphocytic leukemia (CLL), have…
June – A Month to Celebrate Cancer Survivorship
June is a month of commemoration and appreciation for the indomitable spirit of those who have triumphed over cancer. Cancer Survivor Month provides an opportunity…
Subcutaneous Rituximab Demonstrates Superior Outcomes Compared to Intravenous Administration in low–tumor burden follicular lymphoma – Phase III trial (FLIRT)
Subcutaneous Rituximab Demonstrates Superior Outcomes Compared to Intravenous Administration: Enhanced Complete Response Rates and Prolonged Progression-Free Survival – phase III trial (FLIRT) in low tumor…
How can Artificial intelligence help in medicine?
Artificial intelligence (AI) has the potential to transform medicine in many ways. The machine learning has some examples that may be helpful: Overall, AI has…
The fixed duration or time-limited treatment for chronic lymphocytic leukemia with ibrutinib (IMBRUVICA) and Venetoclax (VENCLEXTA) drug combination
The fixed duration or time-limited treatment for chronic lymphocytic leukemia patients has been an attractive option. The time-limited treatment means that patients can be observed…
Anticoagulation or blood thinners in irregular heart rhythm (atrial fibrillation) associated with rheumatic heart disease
Atrial fibrillation (AF) is a common arrhythmia seen in patients with rheumatic heart disease (RHD). RHD is a condition that results from damage to the…